Subapriya Rajamanickam, Kumaraguruparan Ramasamy, Nagini Siddavaram
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar-608 002, Tamil Nadu, India.
Clin Biochem. 2006 Nov;39(11):1080-7. doi: 10.1016/j.clinbiochem.2006.06.013. Epub 2006 Aug 5.
To evaluate the effect of ethanolic neem leaf extract (ENLE) on cell proliferation, differentiation and apoptosis associated proteins during 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis.
Hamsters were divided into four groups. The right buccal pouches of animals in group 1 were painted with 0.5% DMBA three times a week. Animals in group 2 painted with DMBA as in group 1, received in addition, intragastric administration of ENLE (200 mg/kg bw) on days alternate to DMBA application. Group 3 animals were given ENLE (200 mg/kg bw) alone. Animals in group 4 served as control. All the animals were sacrificed after an experimental period of 14 weeks. The expression of proliferating cell nuclear antigen (PCNA), cytokeratin, Bcl-2 and p53 in the buccal pouch tissues were investigated using immunohistochemical staining. In addition, the expression of p53 was confirmed by Western blot analysis.
Topical application of DMBA for 14 weeks induced buccal pouch carcinomas associated with increased expression of PCNA, mutant p53 and Bcl-2 and decreased expression of cytokeratin. Administration of ENLE significantly inhibited the development of HBP carcinomas as revealed by decreased expression of PCNA, mutant p53 and Bcl-2 and overexpression of cytokeratin.
These findings suggest that ENLE exerts its anticancer properties by inhibiting cell proliferation and inducing differentiation and apoptosis.
评估乙醇提取的印楝叶提取物(ENLE)对7,12-二甲基苯并[a]蒽(DMBA)诱导的仓鼠颊囊(HBP)癌变过程中细胞增殖、分化及凋亡相关蛋白的影响。
将仓鼠分为四组。第1组动物的右侧颊囊每周涂三次0.5% DMBA。第2组动物涂DMBA的方式同第1组,此外,在涂DMBA的隔日经胃给予ENLE(200 mg/kg体重)。第3组动物仅给予ENLE(200 mg/kg体重)。第4组动物作为对照。在14周的实验期后处死所有动物。采用免疫组织化学染色法研究颊囊组织中增殖细胞核抗原(PCNA)、细胞角蛋白、Bcl-2和p53的表达。此外,通过蛋白质印迹分析证实p53的表达。
局部应用DMBA 14周可诱导颊囊癌,伴有PCNA、突变型p53和Bcl-2表达增加以及细胞角蛋白表达降低。给予ENLE可显著抑制HBP癌的发展,表现为PCNA、突变型p53和Bcl-2表达降低以及细胞角蛋白表达上调。
这些发现表明,ENLE通过抑制细胞增殖、诱导分化和凋亡发挥其抗癌特性。